CONTROLLED EVIDENCE RELEASE · PUBLIC-STATE-2026-09-25

Proof with a boundary.

Public credibility does not require publishing the mechanism. Every number below includes its provenance, limitations, and explicit disclosure boundary.

LEDGER

Approved aggregate evidence.

These records are generated from the current public-summary contract, not from direct access to private experiment files.

01live forward validation

15 / 11

UBS sets / Deriv synthetic indices

Provenance: Dedicated $1,000 Deriv live research account with a public MQL5 Signal record.
Disclosure limit: The observation is new and has not yet established a durable live edge. Rules, parameters, exact mappings, allocations, and internal monitoring thresholds are not published.

02discovery completed

171

free-EA final dispositions

Provenance: Approved aggregate from the frozen, complete executable free-source corpus.
Disclosure limit: No new deployable edge resulted; identities, implementation details, and case-level evidence are not published.

03tested evidence

227

frozen broker-runtime cases

Provenance: Eighty-five public-source-derived cases and 142 independently expressed native cases were tested under a frozen broker campaign.
Disclosure limit: No implementation, market mapping, testing configuration, or trade-level result is published.

04commercial intelligence

8,962

commercial product identities

Provenance: Approved aggregate from the active commercial-EA research registry.
Disclosure limit: A registry entry is not an endorsement. No newly researched product is currently purchase-ready or authorized for portfolio admission.

05licensed demo book

Deriv research configurations

Provenance: Approved aggregate from the newly packaged licensed-strategy Deriv demo portfolio.
Disclosure limit: The underlying configurations, markets, horizons, selection evidence, and portfolio construction remain confidential.

06range intake

1,529

normalized research configurations

Provenance: Approved aggregate after provenance, archive, duplicate, and compatibility reconciliation in the active range-oriented intake.
Disclosure limit: Intake scale is not evidence of profitability; identities, markets, horizons, settings, and screening outcomes remain confidential.

07promoted to shadow

broker-native diagnostic survivors

Provenance: Approved aggregate after 22,878 cells in the completed literal-transfer study across the supported synthetic-market universe.
Disclosure limit: Shadow promotion is not portfolio admission; no deployment or live-capital authority resulted.

08deployed

publicly linked live research lanes

Provenance: Darwinex Zero and Deriv now each have a public MQL5 Signal record.
Disclosure limit: Acknowledgement does not disclose the shared or distinct contents of either portfolio.

09research rejected

69,447

causal session-study trades

Provenance: Approved aggregate from a verified multi-market study of 88 generalized session-handoff expressions.
Disclosure limit: No trade list is published. No expression passed development and every later block; exact definitions and markets remain confidential.

STANDARD

What a public number must carry.

State

Backtest, validation, forward, and live evidence are never presented as interchangeable.

Provenance

The source class and approval date travel with the claim.

Limitation

What the number cannot establish is published beside what it can.

Confidentiality

A metric is withheld when it could expose the portfolio, even if it is otherwise interesting.